D.E. Shaw & Co
INSY

D.E. Shaw & Co’s Insys Therapeutics, Inc. INSY Stock Holding History

D.E. Shaw & Co’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-37,800
Closed -$590K – 4534
2014
Q2 		$590K Sell
37,800
-60,000
-61% -$970K ﹤0.01% 3395
2014
Q1 		$2.03M Buy
+97,800
New +$1.94M ﹤0.01% 2376

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

D.E. Shaw & Co's INSY Position: Q2 2019 in Review

D.E. Shaw & Co sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 324,957 shares — an estimated $1.5M sold.

D.E. Shaw & Co first reported a position in INSY in Q3 2013 and held it in 15 quarters. The position peaked at $6.33M in Q1 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • D.E. Shaw & Co reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 324,957 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $1.5M.
  • D.E. Shaw & Co first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Insys Therapeutics, Inc. position peaked at $6.33M in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.